NCT02616796

Brief Summary

The purpose of the study is to evaluate a 2-3 day treatment probe targeted to improving social gaze behavior in children with fragile X syndrome (FXS). The investigators will use the principles of Applied Behavior Analysis (ABA) to shape appropriate social skills. Importantly, the investigators propose to examine the effects of this treatment probe on brain and behavior.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Apr 2015

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 30, 2015

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

5.7 years

First QC Date

November 25, 2015

Last Update Submit

November 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Percentage of social gaze aversion recorded during the social challenge

    3 days

  • Heart rate recorded during the social challenge

    3 days

  • Total t-score on the Social Responsiveness Scale (SRS)

    4 weeks

Secondary Outcomes (2)

  • Verbal responses and pauses in conversation observed during the social challenge

    3 days

  • Fractional Amplitude of Low Frequency fluctuations (fALLF) measured in the insular cortex

    3 days

Study Arms (2)

Social gaze training

EXPERIMENTAL

Appropriate social gaze behavior will be reinforced using the principles of Applied Behavior Analysis.

Behavioral: Social gaze training

No Training

NO INTERVENTION

Appropriate social gaze behavior will not be reinforced.

Interventions

Appropriate social gaze behavior will be shaped using the principles of Applied Behavior Analysis.

Social gaze training

Eligibility Criteria

Age8 Years - 18 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Boys diagnosed with fragile X syndrome
  • Boys with intellectual disability who do not have FXS or other known genetic disorder associated with intellectual disability
  • Age 8 to 18 years inclusive
  • Ability to travel to Stanford
  • Vineland Adaptive Behavior Scales standard score between 50 and 75 points

You may not qualify if:

  • Sensory impairments, or any other serious medical or neurological condition that affects growth or development (e.g., seizure disorder, diabetes, congenital heart disease).
  • Materials in body that would preclude an MRI scan (e.g., dental braces).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Publications (1)

  • Gannon CE, Britton TC, Wilkinson EH, Hall SS. Improving social gaze behavior in fragile X syndrome using a behavioral skills training approach: a proof of concept study. J Neurodev Disord. 2018 Aug 28;10(1):25. doi: 10.1186/s11689-018-9243-z.

MeSH Terms

Conditions

Fragile X SyndromeIntellectual Disability

Condition Hierarchy (Ancestors)

X-Linked Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSex Chromosome DisordersChromosome DisordersCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornGenetic Diseases, X-LinkedHeredodegenerative Disorders, Nervous SystemSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 25, 2015

First Posted

November 30, 2015

Study Start

April 1, 2015

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

November 9, 2023

Record last verified: 2023-11

Locations